Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology.Samumed adopted a fresh operating philosophy from thebeginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.

Health Care

Biotechnology

Biosplice Therapeutics

Cevdet Samikoglu

Mirta Grifman

SAM NAMIQ

Scott Bulcao

Osman Kibar

John Hill

Erich Horsley

Christopher Swearingen

Leadership Team

Research and Development

Clinical Operations

Finance and Accounting

Teams at Biosplice Therapeutics

Leadership Team

Research and Development

Clinical Operations

Finance and Accounting